These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30274310)

  • 21. Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers.
    Yi S; Cho JY; Lim KS; Kim KP; Kim J; Kim BH; Hong JH; Jang IJ; Shin SG; Yu KS
    Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):249-56. PubMed ID: 19422358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
    Kontijevskis A; Komorowski J; Wikberg JE
    J Chem Inf Model; 2008 Sep; 48(9):1840-50. PubMed ID: 18693719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Central Role of Cytochrome P450 in Xenobiotic Metabolism-A Brief Review on a Fascinating Enzyme Family.
    Esteves F; Rueff J; Kranendonk M
    J Xenobiot; 2021 Jun; 11(3):94-114. PubMed ID: 34206277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput fluorescence assay for cytochrome P450 mechanism-based inactivators.
    Kenaan C; Zhang H; Hollenberg PF
    Methods Mol Biol; 2013; 987():61-9. PubMed ID: 23475667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of cytochrome P450 enzymes CYP2C8, CYP2C9, CYP2C19 and CYP3A4 by Labisia pumila extracts.
    Pan Y; Tiong KH; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
    J Ethnopharmacol; 2012 Sep; 143(2):586-91. PubMed ID: 22885070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
    Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK
    Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The in vitro inhibition and induction of cytochrome P450 activities by bentysrepinine: a novel candidate of anti-hepatitis B virus drug].
    Fan HR; Ci XY; Li W; Dong SQ; Zeng Y; Yi XL; Si DY; Liu CX
    Yao Xue Xue Bao; 2016 Dec; 51(12):1864-70. PubMed ID: 29908557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
    Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
    Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput mass spectrometric cytochrome P450 inhibition screening.
    Lim KB; Ozbal CC; Kassel DB
    Methods Mol Biol; 2013; 987():25-50. PubMed ID: 23475665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry.
    Lahoz A; Donato MT; Castell JV; Gómez-Lechón MJ
    Curr Drug Metab; 2008 Jan; 9(1):12-9. PubMed ID: 18220567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro approaches to investigate cytochrome P450 activities: update on current status and their applicability.
    Ong CE; Pan Y; Mak JW; Ismail R
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1097-113. PubMed ID: 23682848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts.
    Alnaqeeb M; Mansor KA; Mallah EM; Ghanim BY; Idkaidek N; Qinna NA
    BMC Complement Altern Med; 2019 Jan; 19(1):29. PubMed ID: 30678660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail.
    Dinger J; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2014 Jul; 406(18):4453-64. PubMed ID: 24830396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
    Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
    Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of a column-switching LC/MS/MS method in cytochrome P450 inhibition assays using human liver microsomes.
    Behera D; Pattem R; Kumar MS; Gudi GS
    Drug Metabol Drug Interact; 2013; 28(3):177-85. PubMed ID: 23729559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a miniaturized 384-well high throughput screen for the detection of substrates of cytochrome P450 2D6 and 3A4 metabolism.
    Kariv I; Fereshteh MP; Oldenburg KR
    J Biomol Screen; 2001 Apr; 6(2):91-9. PubMed ID: 11689103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism.
    Ansede JH; Thakker DR
    J Pharm Sci; 2004 Feb; 93(2):239-55. PubMed ID: 14705182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis /LC-MS/MS.
    Zambon S; Fontana S; Kajbaf M
    Drug Metab Lett; 2010 Aug; 4(3):120-8. PubMed ID: 20642444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.